Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany; University Heart Centre Lübeck, Department of Cardiology, Angiology, and Intensive Care Medicine, University Hospital Schleswig-Holstein, Lübeck, Germany.
University Heart Centre Lübeck, Department of Cardiology, Angiology, and Intensive Care Medicine, University Hospital Schleswig-Holstein, Lübeck, Germany.
JACC Clin Electrophysiol. 2020 Dec 14;6(13):1687-1697. doi: 10.1016/j.jacep.2020.07.003. Epub 2020 Sep 16.
This study sought to evaluate the safety and effectiveness of electrical isolation of the left atrial appendage (LAAEI) as well as the status of left atrial appendage closure (LAAC) in these patients.
Catheter-based LAAEI is increasingly performed for treatment of symptomatic atrial fibrillation and pulmonary vein isolation nonresponders. Previous studies indicate an increased incidence of thromboembolic events after LAAEI despite effective oral anticoagulation. Interventional LAAC may prevent cardioembolic events after LAAEI but data regarding safety, feasibility, and efficacy of LAAC in this clinical setting are scarce.
Consecutive patients who underwent LAAEI at 2 German tertiary care hospitals were analyzed.
A total of 270 patients underwent LAAEI by radiofrequency ablation in 255 (94.4%), cryoballoon ablation in 12 (4.4%), and by a combination of both techniques in 3 cases (1.1%). Stroke or transient ischemic attack occurred in 24 of 244 (9.8%) individuals with available follow-up. LAA thrombus formation was found in 53 patients (19.6%). A total of 150 patients underwent LAAC after LAAEI. No LAA thrombus was documented in any patient who underwent LAAC. Of the patients who underwent LAAEI, 67.6% were in sinus rhythm after a mean of 682.7 ± 61.7 days. LAA flow after LAAEI but not arrhythmia recurrence was identified as an independent predictor of stroke and/or transient ischemic attack or LAA thrombus (p < 0.0001).
Sinus rhythm was documented in about two-third of patients undergoing LAAEI as treatment of therapy refractory atrial arrhythmias. LAAC potentially prevents LAA thrombus formation and thromboembolism.
本研究旨在评估电隔离左心耳(LAAEI)的安全性和有效性,以及这些患者左心耳封堵(LAAC)的状况。
基于导管的 LAAEI 越来越多地用于治疗有症状的心房颤动和肺静脉隔离无反应者。尽管进行了有效的口服抗凝治疗,但先前的研究表明,LAAEI 后血栓栓塞事件的发生率增加。介入性 LAAC 可能会预防 LAAEI 后的心源性栓塞事件,但关于这种临床情况下 LAAC 的安全性、可行性和疗效的数据很少。
分析了在德国 2 家三级护理医院接受 LAAEI 的连续患者。
共有 270 例患者接受了射频消融(255 例,94.4%)、冷冻球囊消融(12 例,4.4%)或两者联合(3 例,1.1%)的 LAAEI。在 244 例有随访资料的患者中,有 24 例(9.8%)发生了中风或短暂性脑缺血发作。53 例患者(19.6%)发现左心耳血栓形成。共有 150 例患者在 LAAEI 后接受了 LAAC。在接受 LAAC 的患者中,没有发现任何患者有左心耳血栓。在接受 LAAEI 的患者中,67.6%的患者在平均 682.7±61.7 天后恢复窦性心律。LAAEI 后的左心耳血流而不是心律失常复发被确定为中风和/或短暂性脑缺血发作或左心耳血栓的独立预测因素(p<0.0001)。
作为治疗抗心律失常治疗无效的心房颤动的方法,约三分之二的患者记录到窦性心律。LAAC 可能预防左心耳血栓形成和血栓栓塞。